Tennagels; Norbert

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tennagels; Norbert.The latest application filed is for "conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein".

Company Profile

2.28.35

Tennagels; Norbert - Frankfurt am Main DE
Tennagels; Norbert - Frankfurt N/A DE
Tennagels; Norbert - Siegburg N/A DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Insulin analogs with reduced affinity to insulin receptor and use thereof Grant 11,396,534 - Choi , et al. July 26, 2	2022-07-26
Conjugates Of A Pharmaceutical Agent And A Moiety Capable Of Binding To A Glucose Sensing Protein App 20210401946 - PETRY; Stefan ; et al.	2021-12-30
Conjugates Of A Pharmaceutical Agent And A Moiety Capable Of Binding To A Glucose Sensing Protein App 20210401947 - PETRY; Stefan ; et al.	2021-12-30
Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein Grant 11,090,364 - Petry , et al. August 17, 2	2021-08-17
Insulin Analogs With Reduced Affinity To Insulin Receptor And Use Thereof App 20190300593 - CHOI; In Young ; et al.	2019-10-03
Conjugates Of A Pharmaceutical Agent And A Moiety Capable Of Binding To A Glucose Sensing Protein App 20190209656 - PETRY; Stefan ; et al.	2019-07-11
Cardiac Metabolic Effect Of Lantus App 20180369342 - Wohlfahrt; Paulus ; et al.	2018-12-27
Insulin derivatives having an extremely delayed time-action profile Grant 9,644,017 - Habermann , et al. May 9, 2	2017-05-09
Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases Grant 8,933,024 - Petry , et al. January 13, 2	2015-01-13
Azole derivatives in the form of lipase and phospholipase inhibitors Grant 8,921,404 - Zoller , et al. December 30, 2	2014-12-30
Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors Grant 8,735,437 - Zoller , et al. May 27, 2	2014-05-27
Insulin derivatives having an extremely delayed time-action profile Grant 8,633,156 - Habermann , et al. January 21, 2	2014-01-21
Azolopyridin-3-one Derivatives As Inhibitors Of Lipases And Phospholipases App 20130157941 - Petry; Stefan ; et al.	2013-06-20
Diacyl indazole derivatives as lipase and phospholipase inhibitors Grant 8,357,698 - Zoller , et al. January 22, 2	2013-01-22
Heat- And Vibration-stable Insulin Preparations App 20120241356 - Pfenninger; Anja ; et al.	2012-09-27
Test Systems, Methods And Uses Involving As160 Protein App 20120108464 - Tennagels; Norbert ; et al.	2012-05-03
Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases Grant 8,148,395 - Zoller , et al. April 3, 2	2012-04-03
Benzothiazol-2-one derivatives as lipase and phospholipase inhibitors Grant 8,008,331 - Zoller , et al. August 30, 2	2011-08-30
Novel Insulin Derivatives Having An Extremely Delayed Time-action Profile App 20110173722 - HABERMANN; Paul ; et al.	2011-07-14
Carbamoylbenzotriazole Derivatives As Inhibitors Of Lipases And Phospholipases App 20110118321 - PETRY; Stefan ; et al.	2011-05-19
Novel Insulin Derivatives Having An Extremely Delayed Time-action Profile App 20110077197 - HABERMANN; Paul ; et al.	2011-03-31
Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases Grant 7,897,625 - Petry , et al. March 1, 2	2011-03-01
Imidazopyridin-2-one derivatives as inhibitors of lipases and phospholipases Grant 7,897,616 - Zoller , et al. March 1, 2	2011-03-01
Azolopyridin-2-one Derivatives As Lipase And Phospholipase Inhibitors App 20110039883 - Zoller; Gerhard ; et al.	2011-02-17
Azolopyridin-2-one derivatives as lipase and phospholipase inhibitors Grant 7,846,943 - Zoller , et al. December 7, 2	2010-12-07
Diacyl indazole derivatives as lipase and phospholipase inhibitors App 20100286133 - ZOLLER; Gerhard ; et al.	2010-11-11
Novel As160-like Protein, Test Systems, Methods And Uses Involving It For The Identification Of Diabetes Type 2 Therapeutics App 20100256014 - Tennagels; Norbert ; et al.	2010-10-07
Method for identifying IRS inhibitors or agonists Grant 7,803,571 - Tennagels , et al. September 28, 2	2010-09-28
Diacyl indazole derivatives as lipase and phospholipase inhibitors Grant 7,772,268 - Zoller , et al. August 10, 2	2010-08-10
Benzooxazol-2-one Derivatives As Lipase And Phospholipase Inhibitors App 20100173961 - ZOLLER; Gerhard ; et al.	2010-07-08
Pyrimido[5,4-e][1,2,4]triazine-5-7-diones, processes for preparing them and their use Grant 7,737,144 - Petry , et al. June 15, 2	2010-06-15
Use of IRS-polypeptides for identifying of pharmaceutically active compounds Grant 7,732,151 - Tennagels , et al. June 8, 2	2010-06-08
Benzooxazol-2-one derivatives as lipase and phospholipase inhibitors Grant 7,709,513 - Zoller , et al. May 4, 2	2010-05-04
Imidazolidine Carboxamide Derivatives As Lipase And Phospholipase Inhibitors App 20100105719 - ZOLLER; Gerhard ; et al.	2010-04-29
Imidazopyridin-2-one Derivatives As Inhibitors Of Lipases And Phospholipases App 20090076068 - Zoller; Gerhard ; et al.	2009-03-19
Azolopyridin-3-one Derivatives As Inhibitors Of Lipases And Phospholipases App 20090054478 - Zoller; Gerhard ; et al.	2009-02-26
Carbamoylbenzotriazole Derivatives As Inhibitors Of Lipases And Phospholipases App 20080287503 - Petry; Stefan ; et al.	2008-11-20
Diacyl indazole derivatives as lipase and phospholipase inhibitors App 20080287448 - Zoller; Gerhard ; et al.	2008-11-20
Substituted oxazolobenzoisothiazole dioxide derivatives method for production and use thereof Grant 7,453,000 - Petry , et al. November 18, 2	2008-11-18
Hydroxybiphenyl carboxylic acids and derivatives, method for producing the same and their use Grant 7,453,009 - Petry , et al. November 18, 2	2008-11-18
Benzooxazol-2-one Derivatives As Lipase And Phospholipase Inhibitors App 20080167355 - ZOLLER; Gerhard ; et al.	2008-07-10
Azolopyridin-2-one Derivatives As Lipase And Phospholipase Inhibitors App 20080167339 - ZOLLER; Gerhard ; et al.	2008-07-10
Benzothiazol-2-one Derivatives As Lipase And Phospholipase Inhibitors App 20080161370 - Zoller; Gerhard ; et al.	2008-07-03
Azole Derivatives In The Form Of Lipase And Phospholipase Inhibitors App 20080090867 - Zoller; Gerhard ; et al.	2008-04-17
Pyrimido[5,4-e][1,2,4]triazine-5,7-diones, processes for preparing them and their use App 20080032984 - Petry; Stefan ; et al.	2008-02-07
Hydroxybiphenyl Carboxylic Acids And Derivatives, Method For Producing The Same And Their Use App 20080027134 - PETRY; Stefan ; et al.	2008-01-31
Use of IRS-polypeptides for identifying of pharmaceutically active compounds App 20080020399 - Tennagels; Norbert ; et al.	2008-01-24
Diphenylamine-substituted Salicylthiazole Derivatives And Related Compounds As Phosphotyrosine Phosphatase 1b (ptb1b) Inhibitors For Using As Blood-sugar Decreasing Active Ingredients For Treating Diabetes App 20070191441 - Petry; Stefan ; et al.	2007-08-16
Substituted Oxazolobenzoisothiazole Dioxide Derivatives Method For Production And Use Thereof App 20070149511 - Petry; Stefan ; et al.	2007-06-28
Bicyclic inhibitors of hormone sensitive lipase Grant 7,208,504 - Petry , et al. April 24, 2	2007-04-24
Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use Grant 7,094,794 - Petry , et al. August 22, 2	2006-08-22
Method for the identification of IRS protein kinase inhibitors or agonist App 20050106653 - Tennagels, Norbert ; et al.	2005-05-19
Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use App 20050070533 - Petry, Stefan ; et al.	2005-03-31
Pyrimido[5,4-e][1,2,4]triazine-5,7-diones, processes for preparing them and their use App 20040242583 - Petry, Stefan ; et al.	2004-12-02
Novel bicyclic inhibitors of hormone sensitive lipase App 20040127484 - Petry, Stefan ; et al.	2004-07-01
Highly sensitive and continuous protein tyrosine phosphatase test using 6,8-difluoro-4-methylumbelliferyl phosphate App 20030180827 - Welte, Stefan ; et al.	2003-09-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.